Khurem Farooq Founder of Verdiva Bio Backed byGeneral AtlanticRA Capital ManagementChuck FeeneyNeal KokRichard Aldrich LinkedIn SourcesVerdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies — 2025-01 Browse all founders · Browse investors
